This federal contract award is a $14,386.50 firm fixed price purchase order issued by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostic products. The award is for the provision of external run controls required to validate antibody/antigen viral markers on the Ortho 3600 instrument, in compliance with Food and Drug Administration (FDA) and Clinical Laboratory Improvement Amendments (CLIA)...
This is a $13,459.86 firm fixed-price purchase order awarded to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products, by the National Institutes of Health (NIH) Clinical Center. The order is for 25-004737-SEROLOGICAL ASSAYS, with an ultimate completion date of April 14, 2025. LGC Clinical Diagnostics has previously received numerous federal contracts, primarily purchase orders, to provide a variety of diagnostic testing services, validation...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc. for $24,778.00. The contract is for the delivery of SeraCare bioservices, which include quality control tools, reference materials, controls, reagents, and biological materials to support clinical diagnostics, disease prevention, and health promotion initiatives. LGC Clinical Diagnostics, a foreign-owned, for-profit manufacturer, has been awarded...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control...
This is a $8,667.00 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products. The contract is for the provision of SeraCare BioServices, which includes quality control tools and reference materials to support clinical laboratories, molecular diagnostics, serology testing, and other applications. LGC Clinical Diagnostics has previously...
This federal contract award was made to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $10,451.88, was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, for the purchase of Roche Diagnostics products. The contract has a firm fixed price pricing type and an ultimate completion date of May 3, 2018. This award is not...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $10,697.52 contract provides for the delivery of critical care analyzers, reagents, test kits, and related equipment, supplies, and services to support laboratory capabilities at NIH research centers. This award is not...
This federal contract award is for the provision of in vitro diagnostics, reagents, laboratory instruments, and associated products and services by Roche Diagnostics Corporation to the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The $159,806.92 firm fixed-price purchase order has a completion date of September 11, 2019 and was awarded on July 10, 2018. Roche Diagnostics, a manufacturer and distributor of medical equipment and supplies, has previously...
This is a delivery order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to Roche Diagnostics Corporation for critical medical laboratory equipment and supplies. The $577,863.57 firm-fixed-price contract provides Roche Diagnostics' critical analyzers, reagents, test kits, and associated products and services to support clinical testing capabilities at NIH facilities. This delivery order is issued under Roche's existing General Services...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, for the supply of lab supplies. The potential value of the contract is $119,383.20, and the period of performance runs through April 1, 2019. The contract does not have a set-aside designation. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and...